Annex: Sites and key personnel of contributing MORGAM Centres

© National Institute for Health and Welfare and the MORGAM Project investigators
Last updated: 14 March 2009
For more information, please contact Juha Karvanen (firstname.lastname@thl.fi)

Denmark
- Research Centre for Prevention and Health, Capital Region, Denmark: T. Jørgensen (principal
  investigator), C. Agger, A. Borglykke;
Finland
- FINRISK, National Institute for Health and Welfare, Helsinki: V. Salomaa (principal
  investigator), A. Juolevi, E. Vartiainen, P. Jousilahti;
- MORGAM Data Centre, National Public Health Institute, Helsinki: K. Kuulasmaa
  (head), Z. Cepaitis, A. Haukijärvi, B. Joseph, J. Karvanen, S. Kulathinal, M. Niemelä,
  O. Saarela;
France
- National Coordinating Centre, National Institute of Health and Medical Research
  (U258), Paris: P. Ducimetière (national coordinator), A. Bingham;
- PRIME/Strasbourg, Department of Epidemiology and Public Health, Louis Pasteur
  University, Faculty of Medicine, Strasbourg: D. Arveiler (principal investigator), B.
  Haas, A. Wagner;
- PRIME/Toulouse, Department of Epidemiology, Faculty of Medicine, Toulouse-
  Purpan, Toulouse: J. Ferrières (Principal Investigator), J-B. Ruidavets and V. Bongard;
- PRIME/Lille, Department of Epidemiology and Public Health, Pasteur Institute of
  Lille: P. Amouyel (principal investigator), M. Montaye, J. Dallongeville;
Italy
- National Coordinating Centre MORGAM, Dipartimento di Scienze Cliniche e Biologiche,
  Università degli Studi dell’Insubria, Varese: M. Ferrario (national coordinator), P. Chiodini,
  S. Sarman;
- ITA-BRI, Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi dell’Insubria,
  Varese: M. Ferrario (principle investigator); Dipartimento de Medicina, Prevenzione e
  Biotecnologie Sanitarie, Università degli Studi Milano-Bicocca, Monza: G. Cesana (principal
  investigator), C. Fornari;
- ITA-PAM, Dipartimento de Medicina, Prevenzione e Biotecnologie Sanitarie, Università
  degli Studi Milano-Bicocca, Monza: R. Sega, G. Mancia, R. Faccetti;
- ITA-FRI, Cardiovascular Prevention Centre, ASS4 Medio Friuli and Agenzia Regionale della
  Sanità, Udine: D. Vanuzzo, L. Pilotto, L. Zanier;
- ITA-ROM: Unit of Epidemiology of Cerebro and Cardiovascular Diseases, National Centre
  for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità: S.
  Giampaoli, L. Palmieri, C. Donfrancesco;
Lithuania
- Kaunas, Kaunas University of Medicine, Institute of Cardiology, Kaunas: A. Tamosiunas
  (principal investigator), S. Domarkiene (former principal investigator), D. Rastenyte, G.
  Bernotiene, R. Reklaitiene;
Poland
- Warsaw, Department of Cardiovascular Epidemiology and Prevention, National Institute of
  Cardiology, Warsaw: G. Broda (principal investigator), P. Kurjata, S.L. Rywik, M.
  Polakowska, A. Pytlak;
Sweden
- Northern Sweden, Umeå University Hospital, Medicine, Umeå: M. Eriksson (principal
  investigator), P.-G. Wiklund, B. Stegmayr (former principal investigator);
United Kingdom
- PRIME/Belfast, Queen's University Belfast, Belfast, Northern Ireland: F Kee
  (principal investigator), A. Evans (former principal investigator) J. Yarnell, E.
  Gardner;
- Scotland, University of Dundee, Dundee, Scotland: H. Tunstall-Pedoe (principal investigator),
  R. A'Brook, K. Harrison, J. Gibson;
- Caerphilly, Queen's University Belfast, Belfast, Northern Ireland: J. Yarnell (principal
  investigator), Y. Ben Shlomo, E. Gardner;
- MORGAM Coordinating Centre, Queen's University Belfast, Belfast, Northern
  Ireland: A. Evans (MORGAM coordinator), S. Cashman;
MORGAM Management Group
- A. Evans (chair), S. Blankenberg (Mainz,
  Germany), F. Cambien (Paris, France), M. Ferrario, K. Kuulasmaa, L. Peltonen (Helsinki,
  Finland) , M. Perola (Helsinki, Finland), V. Salomaa, D. Shields (Dublin, Ireland), P.-G.
  Wiklund, H. Tunstall-Pedoe.